WARS1

Tryptophan--tRNA ligase, cytoplasmic · P23381 · WARS1 on Sugi Atlas →

0 patent compounds predicted against WARS1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to WARS1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) PHASE3WITHDRAWN
Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept PHASE3COMPLETED
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC PHASE2COMPLETED
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease PHASE2UNKNOWN
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence nanNOT_YET_RECRUITING
Quantifying Disease Progression in LBSL nanUNKNOWN
Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL) nanRECRUITING
Sirtuin1 in COVID19 Patients nanUNKNOWN
Natural History Study of FDXR Mutation-related Mitochondriopathy nanCOMPLETED
Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
Molecular and Clinical Studies of Primary Immunodeficiency Diseases nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease nanUNKNOWN
Evaluation of the Effects of KCNQ1 Mutation on Insulin Tolerance and Obsessive Compulsive Features in Long QT Romano-Ward Syndrome Patients. nanUNKNOWN
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
I-Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Mitoquines in COPD nanUNKNOWN
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Calf Muscle Strength in Mitochondrial Diseases nanCOMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Genomic of CONgenital Sideroblastic Anemias nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a WARS1 binder may also engage these)

ProteinNameSimilarity
Q5R4J1 1.000 Q5R4J1 →
P17248 1.000 P17248 →
P23612 1.000 P23612 →
P32921 0.998 P32921 →
Q12109 0.997 Q12109 →
Q6P7B0 0.996 Q6P7B0 →
Q9SR15 0.995 Q9SR15 →
Q55DZ8 0.994 Q55DZ8 →
Q6PBS3 0.994 Q6PBS3 →
Q09692 0.991 Q09692 →
Q23670 0.986 Q23670 →
O34764 0.985 O34764 →
Q27128 0.985 Q27128 →
O42130 0.984 O42130 →
Q4ULZ0 0.984 Q4ULZ0 →
Q99XH4 0.984 Q99XH4 →
Q9Y7Y8 0.984 Q9Y7Y8 →
P74241 0.984 P74241 →
Q0CLK1 0.984 Q0CLK1 →
Q60967 0.984 Q60967 →
B7HHH7 0.983 B7HHH7 →
B0T2A6 0.983 B0T2A6 →
O16140 0.982 O16140 →
P0DG60 0.982 P0DG60 →
Q976M1 0.982 Q976M1 →
A9VLJ0 0.982 A9VLJ0 →
Q9WVK4 0.982 Q9WVK4 →
Q91V92 0.981 Q91V92 →
Q5E9R3 0.981 Q5E9R3 →
Q86ZF1 0.981 Q86ZF1 →